209 related articles for article (PubMed ID: 18682522)
1. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ).
Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E
Thorax; 2008 Dec; 63(12):1091-5. PubMed ID: 18682522
[TBL] [Abstract][Full Text] [Related]
2. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
Bernspång E; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
[TBL] [Abstract][Full Text] [Related]
3. Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden.
Tanash HA; Ekström M; Wagner P; Piitulainen E
Int J Chron Obstruct Pulmon Dis; 2016; 11():1663-9. PubMed ID: 27555756
[TBL] [Abstract][Full Text] [Related]
4. Survival in severe alpha-1-antitrypsin deficiency (PiZZ).
Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E
Respir Res; 2010 Apr; 11(1):44. PubMed ID: 20420704
[TBL] [Abstract][Full Text] [Related]
5. Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits.
Tanash HA; Ekström M; Rönmark E; Lindberg A; Piitulainen E
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28889108
[TBL] [Abstract][Full Text] [Related]
6. The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency.
Bernspång E; Carlson J; Piitulainen E
Scand J Gastroenterol; 2009; 44(11):1349-55. PubMed ID: 19891586
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of lung transplantation in individuals with severe α1-anti-trypsin deficiency (PiZZ) and emphysema.
Tanash HA; Riise GC; Hansson L; Nilsson PM; Piitulainen E
J Heart Lung Transplant; 2011 Dec; 30(12):1342-7. PubMed ID: 21821433
[TBL] [Abstract][Full Text] [Related]
8. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
Bernspång E; Sveger T; Piitulainen E
Respir Med; 2007 Sep; 101(9):1971-6. PubMed ID: 17532199
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
Piitulainen E; Tanash HA
COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290
[TBL] [Abstract][Full Text] [Related]
10. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency.
Seersholm N; Kok-Jensen A
Thorax; 1998 Apr; 53(4):265-8. PubMed ID: 9741368
[TBL] [Abstract][Full Text] [Related]
13. Aspects of treatment in alpha 1-antitrypsin deficiency: insights derived from a Swedish PiZZ series.
Eriksson S; Wu MC
Eur Respir J Suppl; 1990 Mar; 9():39s-43s. PubMed ID: 2340050
[TBL] [Abstract][Full Text] [Related]
14. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
15. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).
Piitulainen E; Sveger T
Thorax; 2002 Aug; 57(8):705-8. PubMed ID: 12149531
[TBL] [Abstract][Full Text] [Related]
16. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
[TBL] [Abstract][Full Text] [Related]
17. Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years.
Mostafavi B; Piitulainen E; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2019; 14():525-530. PubMed ID: 30880942
[TBL] [Abstract][Full Text] [Related]
18. [Survival of patients with severe alpha 1-antitrypsin deficiency].
Seersholm NJ; Kok-Jensen A; Dirksen A
Ugeskr Laeger; 1995 Apr; 157(17):2432-5. PubMed ID: 7762099
[TBL] [Abstract][Full Text] [Related]
19. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1-antitrypsin deficiency.
Perlmutter DH
Semin Liver Dis; 1998; 18(3):217-25. PubMed ID: 9773422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
